| 1 | Drug Resistance Updates | 29.1 | 99th | Q1 | SCIE | – | No |
| 2 | Pharmacology and Therapeutics | 28.3 | 99th | Q1 | SCIE | – | No |
| 3 | Drugs | 25.3 | 99th | Q1 | SCIE | – | No |
| 4 | Journal of Biomedical Science | 21.4 | 98th | Q1 | SCIE | – | Yes |
| 5 | Acta Pharmacologica Sinica | 17.7 | 98th | Q1 | SCIE | – | No |
| 6 | OpenNano | 17.3 | 98th | Q1 | – | – | Yes |
| 7 | Nano TransMed | 15 | 97th | Q1 | – | – | Yes |
| 8 | American Journal of Transplantation | 14.4 | 97th | Q1 | SCIE | – | No |
| 9 | Alimentary Pharmacology and Therapeutics | 14 | 96th | Q1 | SCIE | – | No |
| 10 | BioDrugs | 13.8 | 96th | Q1 | SCIE | – | No |
| 11 | CNS Drugs | 13.7 | 96th | Q1 | SCIE | – | No |
| 12 | Chinese Herbal Medicines | 13.5 | 95th | Q1 | ESCI | – | Yes |
| 13 | European Neuropsychopharmacology | 13.2 | 95th | Q1 | SCIE | – | No |
| 14 | Neurotherapeutics | 12.6 | 95th | Q1 | SCIE | – | Yes |
| 15 | npj Breast Cancer | 12.4 | 94th | Q1 | SCIE | – | Yes |
| 16 | Medicine in Drug Discovery | 11.5 | 94th | Q1 | – | – | Yes |
| 17 | Current Neuropharmacology | 11.4 | 94th | Q1 | SCIE | – | No |
| 18 | European Heart Journal - Cardiovascular Pharmacotherapy | 11 | 93rd | Q1 | SCIE | – | No |
| 19 | Journal of Psychopharmacology | 10.3 | 93rd | Q1 | SCIE | – | No |
| 20 | Cancer Drug Resistance | 10.3 | 92nd | Q1 | ESCI | – | No |
| 21 | Antibiotics | 10.2 | 92nd | Q1 | SCIE | – | Yes |
| 22 | Cochrane Database of Systematic Reviews | 10.2 | 92nd | Q1 | SCIE | – | No |
| 23 | Clinical Pharmacology and Therapeutics | 9.9 | 91st | Q1 | SCIE | – | No |
| 24 | npj Vaccines | 9.8 | 91st | Q1 | SCIE | – | Yes |
| 25 | Molecular Therapy Oncology | 9.6 | 91st | Q1 | SCIE | – | Yes |
| 26 | Frontiers in Pharmacology | 9.5 | 90th | Q1 | SCIE | – | Yes |
| 27 | Current Treatment Options in Oncology | 9.3 | 90th | Q1 | SCIE | – | No |
| 28 | Cardiovascular Drugs and Therapy | 9 | 90th | Q1 | SCIE | – | No |
| 29 | European Archives of Psychiatry and Clinical Neuroscience | 8.7 | 89th | Q1 | SCIE | – | No |
| 30 | Inflammopharmacology | 8.7 | 89th | Q1 | SCIE | – | No |
| 31 | Pharmaceutical Research | 8.7 | 89th | Q1 | SCIE | – | No |
| 32 | CNS Neuroscience and Therapeutics | 8.5 | 88th | Q1 | SCIE | – | Yes |
| 33 | Expert Opinion on Investigational Drugs | 8.5 | 88th | Q1 | SCIE | – | No |
| 34 | Antimicrobial Resistance and Infection Control | 8.4 | 87th | Q1 | SCIE | – | Yes |
| 35 | Drug Safety | 8.4 | 87th | Q1 | SCIE | – | No |
| 36 | Pharmaceutical Medicine | 8.4 | 87th | Q1 | ESCI | – | No |
| 37 | International Journal of Antimicrobial Agents | 8.3 | 86th | Q1 | SCIE | – | No |
| 38 | International Journal of Neuropsychopharmacology | 8.3 | 86th | Q1 | SCIE | – | Yes |
| 39 | Rheumatology | 8.3 | 86th | Q1 | SCIE | – | No |
| 40 | Antimicrobial Agents and Chemotherapy | 8 | 85th | Q1 | SCIE | – | Yes |
| 41 | PPAR Research | 7.8 | 85th | Q1 | SCIE | – | Yes |
| 42 | World Journal of Men's Health | 7.8 | 85th | Q1 | SCIE | – | Yes |
| 43 | Frontiers in Medical Technology | 7.8 | 84th | Q1 | ESCI | – | Yes |
| 44 | Vaccines | 7.7 | 84th | Q1 | SCIE | – | Yes |
| 45 | Advances in Therapy | 7.6 | 83rd | Q1 | SCIE | – | No |
| 46 | Cannabis and Cannabinoid Research | 7.6 | 83rd | Q1 | SCIE | – | No |
| 47 | Pharmacopsychiatry | 7.6 | 83rd | Q1 | SCIE | – | No |
| 48 | Clinical Pharmacokinetics | 7.6 | 82nd | Q1 | SCIE | – | No |
| 49 | ADMET and DMPK | 7.5 | 82nd | Q1 | ESCI | – | Yes |
| 50 | British Journal of Clinical Pharmacology | 7.3 | 82nd | Q1 | SCIE | – | No |
| 51 | Drugs and Aging | 7.2 | 81st | Q1 | SCIE | – | No |
| 52 | Pharmacotherapy | 7.2 | 81st | Q1 | SCIE | – | No |
| 53 | Primary Care - Clinics in Office Practice | 7.2 | 81st | Q1 | SCIE | – | No |
| 54 | Drug Metabolism Reviews | 7.1 | 80th | Q1 | SCIE | – | No |
| 55 | Pediatric Drugs | 7 | 80th | Q1 | SCIE | – | No |
| 56 | Therapeutic Advances in Psychopharmacology | 7 | 80th | Q1 | SCIE | – | Yes |
| 57 | Targeted Oncology | 6.9 | 79th | Q1 | SCIE | – | No |
| 58 | Journal of Psychiatry and Neuroscience | 6.7 | 79th | Q1 | SCIE, SSCI | – | No |
| 59 | Journal of Antimicrobial Chemotherapy | 6.6 | 78th | Q1 | SCIE | – | No |
| 60 | Drug and Alcohol Dependence | 6.5 | 78th | Q1 | SCIE, SSCI | – | No |
| 61 | Expert Review of Neurotherapeutics | 6.3 | 78th | Q1 | SCIE | – | No |
| 62 | Cardiovascular Therapeutics | 6.1 | 77th | Q1 | SCIE | – | Yes |
| 63 | Expert Opinion on Drug Safety | 6.1 | 77th | Q1 | SCIE | – | No |
| 64 | Therapeutic Advances in Vaccines and Immunotherapy | 6 | 77th | Q1 | – | – | Yes |
| 65 | American Journal of Cardiovascular Drugs | 6 | 76th | Q1 | SCIE | – | No |
| 66 | Chinese Journal of Integrative Medicine | 5.9 | 76th | Q1 | SCIE | – | No |
| 67 | Expert Review of Clinical Pharmacology | 5.9 | 76th | Q1 | SCIE | – | No |
| 68 | Expert Opinion on Emerging Drugs | 5.9 | 75th | Q1 | SCIE | – | No |
| 69 | Journal of Dietary Supplements | 5.9 | 75th | Q1 | ESCI | – | No |
| 70 | Pulmonary Pharmacology and Therapeutics | 5.9 | 75th | Q1 | SCIE | – | No |
| 71 | Annals of Pharmacotherapy | 5.8 | 74th | Q2 | SCIE | – | No |
| 72 | Investigational New Drugs | 5.8 | 74th | Q2 | SCIE | – | No |
| 73 | International Journal for Parasitology: Drugs and Drug Resistance | 5.8 | 73rd | Q2 | SCIE | – | Yes |
| 74 | Journal of Addiction Medicine | 5.8 | 73rd | Q2 | SCIE | – | No |
| 75 | Clinical Therapeutics | 5.7 | 73rd | Q2 | SCIE | – | No |
| 76 | Pharmacological Research - Modern Chinese Medicine | 5.7 | 72nd | Q2 | – | – | Yes |
| 77 | Advances in Pharmacological and Pharmaceutical Sciences | 5.6 | 72nd | Q2 | ESCI | – | Yes |
| 78 | HIV Medicine | 5.6 | 72nd | Q2 | SCIE | – | No |
| 79 | European Journal of Clinical Pharmacology | 5.6 | 71st | Q2 | SCIE | – | No |
| 80 | Fundamental and Clinical Pharmacology | 5.6 | 71st | Q2 | SCIE | – | No |
| 81 | Recent Patents on Anti-Cancer Drug Discovery | 5.6 | 71st | Q2 | SCIE | – | No |
| 82 | International Clinical Psychopharmacology | 5.6 | 70th | Q2 | SCIE | – | No |
| 83 | Journal of Cardiovascular Pharmacology and Therapeutics | 5.6 | 70th | Q2 | SCIE | – | Yes |
| 84 | Infection and Drug Resistance | 5.6 | 69th | Q2 | SCIE | – | Yes |
| 85 | Photodiagnosis and Photodynamic Therapy | 5.6 | 69th | Q2 | SCIE | – | Yes |
| 86 | Orphanet Journal of Rare Diseases | 5.5 | 69th | Q2 | SCIE | – | Yes |
| 87 | Journal of Cannabis Research | 5.5 | 68th | Q2 | ESCI | – | Yes |
| 88 | Breast Cancer | 5.4 | 68th | Q2 | SCIE | – | No |
| 89 | Therapeutic Advances in Infectious Disease | 5.3 | 68th | Q2 | ESCI | – | Yes |
| 90 | ACS Pharmacology and Translational Science | 5.2 | 67th | Q2 | ESCI | – | No |
| 91 | Vascular Health and Risk Management | 5.2 | 67th | Q2 | ESCI | – | Yes |
| 92 | Clinical Drug Investigation | 5.2 | 66th | Q2 | SCIE | – | No |
| 93 | Clinical Psychopharmacology and Neuroscience | 5.2 | 66th | Q2 | SCIE | – | No |
| 94 | Drug Metabolism and Pharmacokinetics | 5.2 | 66th | Q2 | SCIE | – | No |
| 95 | Therapeutic Advances in Respiratory Disease | 5.1 | 66th | Q2 | SCIE | – | Yes |
| 96 | CPT: Pharmacometrics and Systems Pharmacology | 5.1 | 65th | Q2 | SCIE | – | Yes |
| 97 | PharmaNutrition | 5.1 | 65th | Q2 | ESCI | – | No |
| 98 | Infection and Chemotherapy | 5.1 | 64th | Q2 | ESCI | – | Yes |
| 99 | Journal of Experimental Pharmacology | 5.1 | 64th | Q2 | – | – | Yes |
| 100 | Medical Cannabis and Cannabinoids | 5 | 64th | Q2 | – | – | Yes |
| 101 | International Journal of Clinical Pharmacy | 5 | 63rd | Q2 | SCIE | – | No |
| 102 | Journal of Clinical Pharmacy and Therapeutics | 5 | 63rd | Q2 | SCIE | – | No |
| 103 | Expert Review of Anticancer Therapy | 4.9 | 63rd | Q2 | SCIE | – | No |
| 104 | Advanced Therapeutics | 4.9 | 62nd | Q2 | SCIE | – | No |
| 105 | Antiviral Therapy | 4.9 | 62nd | Q2 | SCIE | – | Yes |
| 106 | European Journal of Drug Metabolism and Pharmacokinetics | 4.9 | 62nd | Q2 | SCIE | – | No |
| 107 | Expert Opinion on Pharmacotherapy | 4.8 | 61st | Q2 | SCIE | – | No |
| 108 | OncoTargets and Therapy | 4.7 | 61st | Q2 | SCIE | – | Yes |
| 109 | Drug Target Insights | 4.7 | 60th | Q2 | ESCI | – | Yes |
| 110 | Journal of Clinical Pharmacology | 4.7 | 60th | Q2 | SCIE | – | No |
| 111 | Journal of Ocular Pharmacology and Therapeutics | 4.7 | 60th | Q2 | SCIE | – | No |
| 112 | Anti-Cancer Drugs | 4.6 | 59th | Q2 | SCIE | – | No |
| 113 | Cancer Chemotherapy and Pharmacology | 4.6 | 59th | Q2 | SCIE | – | No |
| 114 | Therapeutic Advances in Cardiovascular Disease | 4.6 | 59th | Q2 | ESCI | – | Yes |
| 115 | Therapeutic Advances in Drug Safety | 4.6 | 58th | Q2 | SCIE | – | Yes |
| 116 | Biologics: Targets and Therapy | 4.5 | 58th | Q2 | ESCI | – | Yes |
| 117 | Journal of Cardiovascular Development and Disease | 4.5 | 58th | Q2 | SCIE | – | Yes |
| 118 | Human Psychopharmacology | 4.5 | 57th | Q2 | SCIE | – | No |
| 119 | Cancer Innovation | 4.4 | 57th | Q2 | ESCI | – | Yes |
| 120 | EJNMMI Radiopharmacy and Chemistry | 4.3 | 57th | Q2 | ESCI | – | Yes |
| 121 | Australian Prescriber | 4.3 | 56th | Q2 | ESCI | – | Yes |
| 122 | PharmacoEconomics - Open | 4.3 | 56th | Q2 | ESCI | – | Yes |
| 123 | Therapeutic Innovation and Regulatory Science | 4.3 | 55th | Q2 | SCIE | – | No |
| 124 | European Journal of Contraception and Reproductive Health Care | 4.2 | 55th | Q2 | SCIE | – | No |
| 125 | International Journal of Breast Cancer | 4.2 | 55th | Q2 | ESCI | – | Yes |
| 126 | Advances in Clinical and Experimental Medicine | 4.2 | 54th | Q2 | SCIE | – | Yes |
| 127 | Biopharmaceutics and Drug Disposition | 4.2 | 54th | Q2 | SCIE | – | No |
| 128 | Therapeutic Drug Monitoring | 4.2 | 54th | Q2 | SCIE | – | No |
| 129 | Current Reviews in Clinical and Experimental Pharmacology | 4.1 | 53rd | Q2 | ESCI | – | No |
| 130 | Experimental and Clinical Psychopharmacology | 4.1 | 53rd | Q2 | SCIE, SSCI | – | No |
| 131 | Topics in Antiviral Medicine | 4.1 | 53rd | Q2 | – | – | No |
| 132 | BMC Pharmacology and Toxicology | 4.1 | 52nd | Q2 | SCIE | – | Yes |
| 133 | Journal of Chemotherapy | 4.1 | 52nd | Q2 | SCIE | – | No |
| 134 | Clinical Pharmacology: Advances and Applications | 4 | 51st | Q2 | ESCI | – | Yes |
| 135 | Frontiers in Drug Safety and Regulation | 4 | 51st | Q2 | – | – | Yes |
| 136 | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 3.9 | 50th | Q2 | SCIE | – | No |
| 137 | Journal of Clinical Psychopharmacology | 3.9 | 50th | Q2 | SCIE | – | No |
| 138 | Trials | 3.9 | 50th | Q2 | SCIE | – | Yes |
| 139 | Drugs - Real World Outcomes | 3.9 | 49th | Q3 | ESCI | – | Yes |
| 140 | AIDS Research and Therapy | 3.8 | 49th | Q3 | SCIE | – | Yes |
| 141 | Journal of Child and Adolescent Psychopharmacology | 3.8 | 49th | Q3 | SCIE | – | No |
| 142 | Pharmacoepidemiology and Drug Safety | 3.8 | 48th | Q3 | SCIE | – | No |
| 143 | Current Therapeutic Research - Clinical and Experimental | 3.7 | 48th | Q3 | ESCI | – | Yes |
| 144 | Therapeutics and Clinical Risk Management | 3.7 | 48th | Q3 | SCIE | – | Yes |
| 145 | Current Cardiovascular Risk Reports | 3.7 | 47th | Q3 | ESCI | – | No |
| 146 | Exploratory Research in Clinical and Social Pharmacy | 3.6 | 47th | Q3 | ESCI | – | Yes |
| 147 | Chemotherapy | 3.6 | 46th | Q3 | SCIE | – | No |
| 148 | Contemporary Clinical Trials | 3.6 | 46th | Q3 | SCIE | – | No |
| 149 | Journal of Psychedelic Studies | 3.5 | 46th | Q3 | ESCI | – | Yes |
| 150 | AIDS Reviews | 3.5 | 45th | Q3 | SCIE | – | No |
| 151 | Journal of Pharmacy Practice | 3.5 | 45th | Q3 | ESCI | – | No |
| 152 | American Journal of Therapeutics | 3.4 | 45th | Q3 | SCIE | – | No |
| 153 | Expert Review of Pharmacoeconomics and Outcomes Research | 3.4 | 44th | Q3 | SCIE, SSCI | C | No |
| 154 | Clinical Pharmacology in Drug Development | 3.4 | 44th | Q3 | SCIE | – | No |
| 155 | Therapies | 3.3 | 44th | Q3 | SCIE | – | No |
| 156 | Cardiology (Switzerland) | 3.2 | 43rd | Q3 | SCIE | – | No |
| 157 | Drug Metabolism and Personalized Therapy | 3.2 | 43rd | Q3 | – | – | No |
| 158 | Journal of Infection and Chemotherapy | 3.1 | 42nd | Q3 | SCIE | – | No |
| 159 | Nanomedicine Research Journal | 3 | 42nd | Q3 | – | – | Yes |
| 160 | Translational and Clinical Pharmacology | 3 | 42nd | Q3 | ESCI | – | No |
| 161 | Clinica e Investigacion en Arteriosclerosis | 2.9 | 41st | Q3 | ESCI | – | No |
| 162 | International Journal of Pharmacy Practice | 2.9 | 41st | Q3 | ESCI | – | No |
| 163 | Neuropsychopharmacology Reports | 2.9 | 41st | Q3 | ESCI | – | Yes |
| 164 | Iranian Journal of Pharmaceutical Research | 2.9 | 40th | Q3 | SCIE | – | No |
| 165 | Journal of Oncology Pharmacy Practice | 2.7 | 40th | Q3 | SCIE | – | No |
| 166 | Reading Teacher | 2.7 | 40th | Q3 | SSCI | – | No |
| 167 | Journal of Biopharmaceutical Statistics | 2.7 | 39th | Q3 | SCIE | C | No |
| 168 | Clinical Neuropharmacology | 2.7 | 39th | Q3 | SCIE | – | No |
| 169 | International Journal of STD and AIDS | 2.6 | 39th | Q3 | SCIE | – | No |
| 170 | Iraqi Journal of Pharmaceutical Sciences | 2.6 | 38th | Q3 | – | – | Yes |
| 171 | Pharmaceutical Statistics | 2.6 | 38th | Q3 | SCIE | – | No |
| 172 | JACCP Journal of the American College of Clinical Pharmacy | 2.5 | 37th | Q3 | ESCI | – | No |
| 173 | Pharmacia | 2.5 | 37th | Q3 | ESCI | – | Yes |
| 174 | Recent Advances in Anti-Infective Drug Discovery | 2.5 | 37th | Q3 | – | – | No |
| 175 | Precision Cancer Medicine | 2.5 | 36th | Q3 | – | – | No |
| 176 | Pharmaceutical Fronts | 2.3 | 36th | Q3 | ESCI | – | Yes |
| 177 | HIV Research and Clinical Practice | 2.2 | 35th | Q3 | SCIE | – | Yes |
| 178 | Psychopharmacology Bulletin | 2.2 | 35th | Q3 | – | – | No |
| 179 | Indian Journal of Pharmacology | 2.1 | 35th | Q3 | SCIE | – | No |
| 180 | Mental Health Clinician | 2.1 | 34th | Q3 | – | – | Yes |
| 181 | Research Results in Biomedicine | 2.1 | 34th | Q3 | – | – | No |
| 182 | Current Drug Safety | 2 | 33rd | Q3 | ESCI | – | No |
| 183 | Journal of Anaesthesiology Clinical Pharmacology | 2 | 33rd | Q3 | ESCI | – | Yes |
| 184 | Zhongguo Zhongyao Zazhi | 2 | 33rd | Q3 | – | – | No |
| 185 | Journal of Pediatric Pharmacology and Therapeutics | 2 | 32nd | Q3 | – | – | No |
| 186 | Recent Advances in Inflammation and Allergy Drug Discovery | 2 | 32nd | Q3 | ESCI | – | No |
| 187 | Journal of Pain and Palliative Care Pharmacotherapy | 1.9 | 32nd | Q3 | ESCI | – | No |
| 188 | Pharmacoepidemiology | 1.9 | 31st | Q3 | ESCI | – | Yes |
| 189 | Science of Traditional Chinese Medicine | 1.9 | 31st | Q3 | – | – | Yes |
| 190 | Traditional and Kampo Medicine | 1.9 | 31st | Q3 | ESCI | – | No |
| 191 | Hospital Pharmacy | 1.8 | 30th | Q3 | ESCI | – | No |
| 192 | Journal of Pharmacology and Pharmacotherapeutics | 1.8 | 30th | Q3 | ESCI | – | No |
| 193 | Indonesian Journal of Pharmacy | 1.6 | 30th | Q3 | ESCI | – | Yes |
| 194 | Frontiers in Clinical Drug Research - CNS and Neurological Disorders | 1.6 | 29th | Q3 | – | – | No |
| 195 | Journal of Pharmaceutical Health Care and Sciences | 1.5 | 29th | Q3 | ESCI | – | Yes |
| 196 | Chinese Traditional and Herbal Drugs | 1.5 | 28th | Q3 | – | – | No |
| 197 | International Journal of Clinical Pharmacology and Therapeutics | 1.5 | 28th | Q3 | SCIE | – | No |
| 198 | Research Journal of Pharmacy and Technology | 1.5 | 28th | Q3 | – | – | No |
| 199 | Journal of Pharmacy Practice and Research | 1.5 | 27th | Q3 | ESCI | – | No |
| 200 | Toxicology Communications | 1.4 | 27th | Q3 | ESCI | – | Yes |
| 201 | Canadian Journal of Hospital Pharmacy | 1.3 | 27th | Q3 | ESCI | – | No |
| 202 | Current Drug Therapy | 1.3 | 26th | Q3 | ESCI | – | No |
| 203 | Journal of Research in Pharmacy | 1.3 | 26th | Q3 | ESCI | – | No |
| 204 | Side Effects of Drugs Annual | 1.3 | 26th | Q3 | – | – | No |
| 205 | Rational Pharmacotherapy in Cardiology | 1.3 | 25th | Q3 | ESCI | – | Yes |
| 206 | Borneo Journal of Pharmacy | 1.2 | 25th | Q3 | – | – | Yes |
| 207 | Journal of Nephropharmacology | 1.2 | 25th | Q3 | – | – | Yes |
| 208 | Current Signal Transduction Therapy | 1.2 | 24th | Q4 | – | – | No |
| 209 | Psychiatry and Clinical Psychopharmacology | 1.2 | 24th | Q4 | SCIE | – | Yes |
| 210 | Health Biotechnology and Biopharma | 1.2 | 23rd | Q4 | – | – | No |
| 211 | Open Access Journal of Clinical Trials | 1.2 | 23rd | Q4 | ESCI | – | Yes |
| 212 | Research Results in Pharmacology | 1.2 | 23rd | Q4 | – | – | Yes |
| 213 | Drug and Therapeutics Bulletin | 1.1 | 22nd | Q4 | – | – | No |
| 214 | Journal of Holistic Integrative Pharmacy | 1.1 | 22nd | Q4 | – | – | Yes |
| 215 | Pharmaceutical Sciences Asia | 1.1 | 22nd | Q4 | – | – | Yes |
| 216 | Farmatsiya i Farmakologiya | 1.1 | 21st | Q4 | ESCI | – | Yes |
| 217 | Frontiers in Anesthesiology | 1.1 | 21st | Q4 | ESCI | – | Yes |
| 218 | Drugs and Therapy Perspectives | 1 | 21st | Q4 | ESCI | – | No |
| 219 | Kliniceskaa Mikrobiologia i Antimikrobnaa Himioterapia | 1 | 20th | Q4 | – | – | Yes |
| 220 | Medical Letter on Drugs and Therapeutics | 1 | 20th | Q4 | SCIE | – | No |
| 221 | Journal of Opioid Management | 1 | 19th | Q4 | – | – | No |
| 222 | Majalah Obat Tradisional | 1 | 19th | Q4 | – | – | Yes |
| 223 | International Journal of Cancer Management | 0.9 | 19th | Q4 | ESCI | – | No |
| 224 | International Journal of Nutrition, Pharmacology, Neurological Diseases | 0.9 | 18th | Q4 | – | – | No |
| 225 | Reviews on Clinical Pharmacology and Drug Therapy | 0.9 | 18th | Q4 | – | – | No |
| 226 | Tropical Journal of Pharmaceutical Research | 0.9 | 18th | Q4 | – | – | Yes |
| 227 | Current Topics in Pharmacology | 0.9 | 17th | Q4 | – | – | No |
| 228 | Journal of Cellular and Molecular Anesthesia | 0.9 | 17th | Q4 | – | – | No |
| 229 | Methods in Pharmacology and Toxicology | 0.9 | 17th | Q4 | – | – | No |
| 230 | Annals of Cancer Research and Therapy | 0.8 | 16th | Q4 | – | – | No |
| 231 | Chinese Journal of Hospital Pharmacy | 0.8 | 16th | Q4 | – | – | No |
| 232 | Sovremennaya Revmatologiya | 0.8 | 16th | Q4 | – | – | Yes |
| 233 | Chinese Journal of Infection and Chemotherapy | 0.7 | 15th | Q4 | – | – | No |
| 234 | Journal of Arrhythmology | 0.7 | 15th | Q4 | – | – | Yes |
| 235 | International Journal of Pharmaceutical Sciences and Nanotechnology | 0.7 | 14th | Q4 | – | – | No |
| 236 | Trends in Immunotherapy | 0.7 | 14th | Q4 | – | – | No |
| 237 | Modern Medical Technology | 0.6 | 14th | Q4 | – | – | Yes |
| 238 | Adverse Drug Reaction Bulletin | 0.6 | 13th | Q4 | – | – | No |
| 239 | Biomedical and Biopharmaceutical Research | 0.6 | 13th | Q4 | – | – | No |
| 240 | Opuholi Zenskoj Reproduktivnoj Sistemy | 0.6 | 13th | Q4 | – | – | No |
| 241 | Infectio | 0.6 | 12th | Q4 | ESCI | – | Yes |
| 242 | Chinese Journal of New Drugs | 0.5 | 12th | Q4 | – | – | No |
| 243 | Vojnosanitetski Pregled | 0.5 | 12th | Q4 | SCIE | – | Yes |
| 244 | Opuholi Golovy i Sei | 0.5 | 11th | Q4 | – | – | No |
| 245 | Pediatricheskaya Farmakologiya | 0.5 | 11th | Q4 | – | – | Yes |
| 246 | Journal of Health Policy and Outcomes Research | 0.5 | 10th | Q4 | – | – | Yes |
| 247 | Revista Colombiana de Ciencias Quimico-Farmaceuticas (Colombia) | 0.5 | 10th | Q4 | – | – | No |
| 248 | Russian Military Medical Academy Reports | 0.5 | 10th | Q4 | – | – | No |
| 249 | Prescrire International | 0.5 | 9th | Q4 | – | – | No |
| 250 | Indonesian Journal of Tropical and Infectious Disease | 0.4 | 9th | Q4 | – | – | Yes |
| 251 | Phytotherapy Journal | 0.4 | 9th | Q4 | – | – | No |
| 252 | Chinese Journal of Clinical Pharmacology and Therapeutics | 0.4 | 8th | Q4 | – | – | No |
| 253 | International Journal of Pharmaceutical Compounding | 0.4 | 8th | Q4 | – | – | No |
| 254 | Odesa Medical Journal | 0.4 | 8th | Q4 | – | – | No |
| 255 | Adverse Drug Reactions Journal | 0.3 | 7th | Q4 | – | – | No |
| 256 | Journal de Pharmacie Clinique | 0.3 | 7th | Q4 | – | – | No |
| 257 | Pharmacien Clinicien | 0.3 | 7th | Q4 | – | – | No |
| 258 | Cancer and Chemotherapy Reviews | 0.3 | 6th | Q4 | – | – | No |
| 259 | Drugs and Clinic | 0.3 | 6th | Q4 | – | – | No |
| 260 | Actualites Pharmaceutiques | 0.2 | 5th | Q4 | ESCI | – | No |
| 261 | Modern Gastroenterology | 0.2 | 5th | Q4 | – | – | No |
| 262 | Psychopharmakotherapie | 0.2 | 5th | Q4 | – | – | No |
| 263 | Giornale Italiano di Farmacia Clinica | 0.2 | 4th | Q4 | – | – | No |
| 264 | Japanese Journal of Clinical Pharmacology and Therapeutics | 0.2 | 4th | Q4 | – | – | No |
| 265 | WHO Drug Information | 0.2 | 4th | Q4 | – | – | No |
| 266 | Epitheorese Klinikes Farmakologias kai Farmakokinetikes | 0.1 | 3rd | Q4 | – | – | No |
| 267 | Japanese Journal of Chemotherapy | 0.1 | 3rd | Q4 | – | – | No |
| 268 | Japanese Pharmacology and Therapeutics | 0.1 | 3rd | Q4 | – | – | No |
| 269 | Journal fur Pharmakologie und Therapie | 0.1 | 2nd | Q4 | – | – | No |
| 270 | Krankenhauspharmazie | 0.1 | 2nd | Q4 | – | – | No |
| 271 | Medizinische Monatsschrift fur Pharmazeuten | 0.1 | 1st | Q4 | – | – | No |
| 272 | Arzneimitteltherapie | 0 | 1st | Q4 | – | – | No |
| 273 | Pharmaceutisch Weekblad | 0 | 1st | Q4 | – | – | No |
| 274 | Deutsche Apotheker Zeitung | 0 | 0th | Q4 | – | – | No |
| 275 | Oral Therapeutics and Pharmacology | 0 | 0th | Q4 | – | – | No |
| 276 | Pharmazeutische Zeitung | 0 | 0th | Q4 | – | – | No |